Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-24-000171
Filing Date
2024-11-07
Accepted
2024-11-07 16:17:38
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20240930.htm   iXBRL 10-Q 1350312
2 EX-31.1 CEO CERTIFICATION plrx-20240930xex311.htm EX-31.1 9816
3 EX-31.2 CFO CERTIFICATION plrx-20240930xex312.htm EX-31.2 9783
4 EX-32.1 CEO AND CFO CERTIFICATION plrx-20240930xex321.htm EX-32.1 7295
  Complete submission text file 0001746473-24-000171.txt   6713000

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20240930.xsd EX-101.SCH 52460
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20240930_cal.xml EX-101.CAL 59394
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20240930_def.xml EX-101.DEF 242132
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20240930_lab.xml EX-101.LAB 631541
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20240930_pre.xml EX-101.PRE 453355
86 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20240930_htm.xml XML 726441
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 241436061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)